Treatments in ischemic stroke: current and future
Abstract Background and Aim: Despite progress made over the last 30 years, stroke is still a
leading cause of disability and mortality; likewise, its burden is expected to increase over the …
leading cause of disability and mortality; likewise, its burden is expected to increase over the …
Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological …
Early neurological deterioration (END) following ischaemic stroke is a serious event with
manageable causes in only a fraction of patients. The incidence, causes and predictors of …
manageable causes in only a fraction of patients. The incidence, causes and predictors of …
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
Intravenous thrombolysis is the only approved systemic reperfusion treatment for patients
with acute ischaemic stroke. These European Stroke Organisation (ESO) guidelines provide …
with acute ischaemic stroke. These European Stroke Organisation (ESO) guidelines provide …
Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American …
Background and Purpose—The authors present an overview of the current evidence and
management recommendations for evaluation and treatment of adults with acute ischemic …
management recommendations for evaluation and treatment of adults with acute ischemic …
PKM2 promotes neutrophil activation and cerebral thromboinflammation: therapeutic implications for ischemic stroke
There is a critical need for cerebro-protective interventions to improve the suboptimal
outcomes of patients with ischemic stroke who have been treated with reperfusion …
outcomes of patients with ischemic stroke who have been treated with reperfusion …
Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial
SM Zinkstok, YB Roos - The Lancet, 2012 - thelancet.com
Background Thrombolysis with intravenous alteplase is the only approved treatment for
acute ischaemic stroke. After alteplase-induced recanalisation, reocclusion occurs in 14 …
acute ischaemic stroke. After alteplase-induced recanalisation, reocclusion occurs in 14 …
Tandem internal carotid artery/middle cerebral artery occlusion: an independent predictor of poor outcome after systemic thrombolysis
Background and Purpose—Although tandem internal carotid artery/middle cerebral artery
(MCA; TIM) occlusion has been associated with low recanalization rate after IV tissue …
(MCA; TIM) occlusion has been associated with low recanalization rate after IV tissue …
Инсульт: пошаговая инструкция
МА Пирадов, МЮ Максимова, ММ Танашян - 2019 - elibrary.ru
В руководстве с современных позиций освещены диагностика, лечение и
профилактика инсульта на различных этапах оказания медицинской помощи. Большое …
профилактика инсульта на различных этапах оказания медицинской помощи. Большое …
Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines–Stroke registry
Importance Mild strokes have been poorly represented in thrombolytic trials and only a few
series have reported outcomes after treatment with intravenous (IV) recombinant tissue …
series have reported outcomes after treatment with intravenous (IV) recombinant tissue …
Early neurological deterioration in acute ischaemic stroke: predictors, mechanisms and management
B Thanvi, S Treadwell… - Postgraduate Medical …, 2008 - academic.oup.com
Early neurological deterioration (END) in acute ischaemic stroke is a common event. The
underlying mechanisms are heterogeneous. The clinical predictors of END include severity …
underlying mechanisms are heterogeneous. The clinical predictors of END include severity …